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Abstract: The nitrogenase iron protein (Fe-protein) contains
an unusual [4Fe:4S] iron-sulphur cluster that is stable in three
oxidation states: 2+ , 1+ , and 0. Here, we use spatially
resolved anomalous dispersion (SpReAD) refinement to
determine oxidation assignments for the individual irons for
each state. Additionally, we report the 1.13-c resolution
structure for the ADP bound Fe-protein, the highest resolution
Fe-protein structure presently determined. In the dithionite-
reduced [4Fe:4S]1+ state, our analysis identifies a solvent
exposed, delocalized Fe2.5+ pair and a buried Fe2+ pair. We
propose that ATP binding by the Fe-protein promotes an
internal redox rearrangement such that the solvent-exposed Fe
pair becomes reduced, thereby facilitating electron transfer to
the nitrogenase molybdenum iron-protein. In the [4Fe:4S]0 and
[4Fe:4S]2+ states, the SpReAD analysis supports oxidation
states assignments for all irons in these clusters of Fe2+ and
valence delocalized Fe2.5+, respectively.
Biological nitrogen fixation is a multi-electron redox process
carried out by nitrogenase,[1–3] a two-protein enzyme com-
prised of the iron- and molybdenum iron-proteins (Fe-protein
and MoFe-protein). In the catalytic cycle, electrons originat-
ing from an electron donor (ferredoxin or flavodoxin in vivo
or dithionite in vitro) are passed to the Fe-protein, which
subsequently mediates the ATP-dependent reduction of the
MoFe-protein. The MoFe-protein contains two unique metal-
locofactors: an intermediate [8Fe:7S] P-cluster and the active-
site [Mo:7Fe:9S:C]-R-homocitrate FeMo-cofactor (FeMoco).
Substrate reduction is accomplished through multiple binding
and dissociation events between the MoFe-protein and Fe-
protein, with each cycle involving electron transfer from the
Fe-protein to the MoFe-protein. The timing of the electron
transfers between the constituent clusters in the overall
substrate reduction mechanism is an active area of inves-
tigation.
The Fe-protein is the only electron donor currently known
to efficiently support N2 reduction by nitrogenase. A homo-
dimer, the Fe-protein contains a single [4Fe:4S] cluster
coordinated to the side chains of Cys97 and Cys132 of each
subunit.[4, 5] The cluster has been characterized in three overall
oxidation states: the oxidized [4Fe:4S]2+ and dithionite-
reduced [4Fe:4S]1+ forms identified in early work on nitro-
genase,[1] and the all-ferrous [4Fe:4S]0 form.[6, 7] It is generally
considered that electron transfer from the Fe-protein to the
MoFe-protein uses the 2+ /1+ couple, although a role for the
all-ferrous form has been proposed.[6, 8–10] Changes in the Fe-
protein [4Fe:4S] cluster environment can be monitored
spectroscopically[11–13] and through the accessibility of the
cluster to chelation.[14–16]
Mçssbauer and EPR spectroscopies have been particu-
larly valuable in deciphering the oxidation states in [4Fe:4S]
clusters, including the Fe-protein.[17–20] From the isomer shifts
observed in Mçssbauer spectra, the Fe in [4Fe:4S] clusters
may be assigned as either valence localized sites (Fe2+ or Fe3+)
or as valence delocalized Fe2.5+Fe2.5+ pairs.[19,20] In the case of
the Fe-protein, the S= 1/2 spin state of the [4Fe:4S]1+ form
consists of a delocalized Fe2.5+ pair and a pair of Fe2+. In
contrast, only one type of Fe occurs in each of the other two
cluster forms: the S= 0 state of [4Fe:4S]2+ contains delocal-
ized Fe2.5+ pairs,[17] while in the S= 4 state of [4Fe:4S]0, the
iron sites are all Fe2+.[21] Additional complexities in the
electronic/magnetic structure arise from the variable spin
coupling between the Fe. For example, the [4Fe:4S]1+ cluster
exists as a mixture of S= 1/2 and S= 3/2 spin states with the
precise distribution dependent on the solvent and nucleotide
conditions.[17]
A full understanding of the nitrogenase mechanism must
include the detailed oxidation state assignments of the
component metalloclusters. Assigning oxidation states to
individual metals in a metallocluster is difficult using conven-
tional spectroscopic techniques, due to the ambiguity in
assigning spectral features to specific sites. To circumvent
these limitations, we have developed SpReAD (Spatially
Resolved Anomalous Dispersion) refinement, a combination
of X-ray crystallography and X-ray absorption spectroscopy
to determine site-specific X-ray absorption spectra,[22,23]
building on pioneering work by Coppens.[24] By refining
structures against diffraction data collected at a series of
energies across an absorption edge, the X-ray absorption
spectra of each individual metal site can be obtained from the
corresponding Df” values. For the Fe-protein, oxidation leads
to a shift of the main edge position to higher energies by circa
1 eV per 0.5 change in oxidation state.[25] It should be noted
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that edge positions are sensitive to many factors including the
ligand sphere.[26] The SpReAD method has previously been
used to identify the reduced Fe site in the [2Fe:2S]1+ cluster of
a ferredoxin[22] from Aquifex aeolicus, as well as Fe oxidation
states in the resting form of FeMoco[23] and a mononuclear Fe
site in the Azotobacter vinelandii MoFe-protein.[27] Herein,
we present a comprehensive redox description of the A.
vinelandii Fe-protein [4Fe:4S] cluster in its three possible
oxidation states.
High resolution crystal structures are a prerequisite for
the SpReAD analysis to ensure that the electron densities for
the absorbing iron sites are well defined. Conditions were
identified that permitted the first atomic resolution (1.13 c)
structure of the ADP-bound A. vinelandii Fe-protein (see the
Supporting Information, Methods) (Figure 1). The overall
subunit fold resembles previously determined structures[5, 28,29]
(Supporting Information, Table S1 and Figure S1). The aver-
age iron–iron distances in the atomic-resolution cluster
(Supporting Information, Figure S2) for the dithionite-re-
duced 1+ state with bound ADP are 2.70 c, which is close to
the 2.73c distances observed by extended X-ray absorption
fine structure (EXAFS).[25,30]
To assess the site-specific oxidation state assignments for
Fe in the [4Fe:4S] cluster of the Fe-protein as a function of
overall cluster oxidation state (2+ , 1+ , 0), and in the
presence or absence of ADP, SpReAD analyses were
conducted. Appropriate diffraction data sets were collected
for four forms of the Fe-protein: 1) the dithionite (DT)-
reduced [4Fe:4S]1+ state with ADP, 2) the DT-reduced
[4Fe:4S]1+ state without ADP, 3) indigodisulfonic acid
(IDS)-oxidized [4Fe:4S]2+ with ADP, and 4) the all-ferrous
TiIII-citrate reduced [4Fe:4S]0 state without ADP. Suitable
quality data sets could not be obtained for either the [4Fe:4S]0
form in the presence of ADP or for the [4Fe:4S]2+ state in the
absence of ADP. Intriguingly these forms have less mecha-
nistic relevance as ADP and oxidized Fe-protein are the
physiological products of electron transfer to the MoFe-
protein. Diffraction data were collected along the rising iron
edge centered at 7120 keV using procedures described
previously[22,23] (Supporting Information, Table S2, S3). Pho-
toreduction did not appear to be significant under these
conditions, consistent with observations from X-ray absorp-
tion spectroscopy studies of Fe-protein,[25, 31] although some
contribution to the oxidized 2+ state cannot be eliminated.
To benchmark the SpReAD analysis and assign oxidation
states, reference curves were derived from the MoFe-protein
metalloclusters, with the P-cluster and FeMoco assigned to
reduced Fe2+ and oxidized Fe~2.57+, respectively[23] (Figure 2,
and S3 in the Supporting Information). The FeMoco oxida-
tion state was taken as the average of 4Fe3+ and 3Fe2+.[23]
Absorption curves were compiled for each iron site in
different forms of the Fe-protein [4Fe:4S] cluster and overlaid
with the reference spectra (Figure 2, and S3 in the Supporting
Information). The comparison to the P-cluster absorption
spectra yielded an unambiguous population of Fe2+-like
curves, and a second set of curves were shifted to higher
energy by roughly 1 eV, indicating a more oxidized state
comparable to that of the average Fe-sites in FeMoco. The
curves that aligned with the P-cluster were assigned to the
Fe2+ state, while the data shifted to higher energies are
assigned to the expected Fe2.5+ state.
The SpReAD analysis of the dithionite-reduced state
[4Fe:4S]1+ was completed on the MgADP-bound and nucleo-
tide free structures of Fe-protein. In both cases, the site-
specific X-ray absorption spectra support two distinct
Figure 1. (Left) Electron density for the MgADP molecule and [4Fe:4S]
cluster from the dithionite-reduced, ADP-bound structure at 1.13 b-
resolution. The cluster bridges the dimer interface and 2Fo@Fc map is
contoured at 1s. (Right) The Fe labelling scheme used in this work is
indicated.
Figure 2. SpReAD curves for the three possible oxidation states of the
Fe-protein: A) The IDS-oxidized [4Fe:4S]2+ state with ADP. B) The
dithionite (DT)-reduced [4Fe:4S]1+ state with ADP. C) The dithionite-
reduced [4Fe:4S]1+ state (nucleotide free). D) The TiIII-citrate-reduced
[4Fe:4S]0 state (nucleotide free). The structures used for the data
depicted in panels A and B contain a crystallographic two-fold axis of
symmetry through the cluster and so Fe1 and Fe3 are equivalent, as
are Fe2 and Fe4. The structures used for the data depicted in panels C
and D contain an entire [4Fe:4S] cluster in the asymmetric unit, and
so the absorption curves for each Fe are presented. More-reduced
profiles are coded in red, more-oxidized profiles are coded in blue. For
reference, the SpReAD profiles of the dithionite-reduced state of the
MoFe-protein metalloclusters are plotted: the average Fe curve for the
all-ferrous P-cluster (red dots) and the more oxidized average of all Fe
in FeMoco (ca. Fe2.57+) (blue dots). The sulphur anomalous (green) is
also shown; at 7100 eV, the expected value of f’’ is 0.70e (skuld.bmsc.-
washington.edu/scatter/data/S.dat).
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[2Fe:2S] sublayers perpendicular to the two-fold axis of the
protein dimer. The sublayer facing the protein surface
(coordinated by Cys97 Sg)) is assigned to the more oxidized
valence delocalized Fe2.5+–Fe2.5+ iron sites, while the sublayer
facing the interior of the protein (coordinated by Cys132 Sg)
is assigned as two Fe2+. In contrast, the absorption curves for
the Fe in the fully-reduced [4Fe4S]0 agree well with the P-
cluster reference state, supporting a consistent oxidation state
description of Fe2+ for all sites. The absorption curves for the
fully oxidized [4Fe4S]2+ state are shifted to higher energy as
anticipated for the Fe2.5+ state, but the curves differ in shape
from the reference FeMoco (Figure 2, and S3 in the Support-
ing Information).
To confirm that the electronic state of the [4Fe:4S]1+
cluster in the crystal reflected the solution properties,
perpendicular-mode electron paramagnetic resonance
(EPR) was used. A polycrystalline sample of the [4Fe:4S]1+
nucleotide-free protein crystals (used in SpReAD experi-
ments) was prepared and compared to the respective protein-
solution sample by EPR (Figure 3, see the Supporting
Information, Methods). Solution-state samples produced
a rhombic spectrum with a strong S= 1/2 feature at g= 1.94
with no other low-field features. Spectra of Fe-protein crystals
similarly showed a predominant S= 1/2 feature, with an
additional signal at g= 4.3 (4% of the g= 1.9 integrated peak
area). Previous studies have attributed the g= 4.3 signal to
adventitious Fe3+, or an S= 5/2 system by Mçssbauer
spectroscopy[30] reflective of the ATP-bound state. However,
the crystal structure of our sample is well ordered and shows
no bound nucleotide. The resting state of the Fe-protein is
considered to be a mixture of S= 1/2 and S= 3/2 spin states,[17]
and the absence of the S= 3/2 signal may reflect the solvent
dependence of the equilibrium.[17]
During the process of substrate reduction by nitrogenase,
the Fe-protein cycles through a series of conformations
coupled to distinct nucleotide and cluster oxidation states.
The crystal structures reveal distinct patterns of hydrogen
bonds surrounding the cluster associated with the presence or
absence of MgADP (Figure 4). Although the underlying basis
for one hydrogen bond pattern relative to the other is not
evident, the MgADP conformation is observed in the 1+ and
2+ oxidation states, while the nucleotide free conformation is
observed in 0 and 1+ states, suggesting that the MgADP
conformation interacts preferentially with the more oxidized
forms of the [4Fe:4S] cluster.
An important feature of the nitrogenase mechanism is
that the [4Fe:4S]1+ state of the cluster serves as the electron
donor to theMoFe-protein only in the MgATP bound form of
the Fe-protein, but not in the nucleotide free and MgADP-
bound states. Interestingly, the SpReAD analysis on the latter
two structures establishes that the two Fe in the [4Fe:4S]
cluster closest to the surface are more oxidized relative to the
more buried Fe. The redox competent form of the Fe-protein
might be expected to have the reduced Fe nearer to the
surface to facilitate electron transfer into theMoFe-protein. If
so, MgATP could promote an internal redox rearrangement
such that the positions of the Fe2+ and Fe2.5+ are switched. The
binding of ATP has been associated with a decrease (ca.
100 mV) in the reduction potential of the cluster,[32] as well as
changes in the EPR. A further intriguing observation is that in
the [4Fe:4S]1+ form, despite the surface exposed cluster, only
the MgATP-bound form is chelated by a,a-dipyridyl and
related compounds. These chelators have a higher affinity for
Fe2+ relative to Fe3+ (estimated to be ca. 106, based on the
reduction potential of 1.12 V[33]). One explanation for this
behavior is that the surface exposed Fe are Fe2+ in the
MgATP-bound form and the enhanced reactivity with the
chelator reflects their reduced state.
Complete understanding of the Fe-protein catalytic cycle
will require the structural analysis of the MgATP-bound form
that has evaded crystallization for over 25 years. The cumu-
lative SpReAD analysis described herein and in the previous
work on the MoFe-protein[23] provide an assignment of the
site specific redox states of the resting forms of the nitro-
Figure 3. EPR spectra of Fe-protein in the [4Fe4S]1+ state in solution
(black) and in a crystal slurry (red). Simulated spectrum in blue.
Inserts show the expanded g=2 and g=4 regions.
Figure 4. Hydrogen bonding patterns observed in the Fe-protein
structures: A) The IDS-oxidized [4Fe:4S]2+ state with ADP. B) The
dithionite-reduced [4Fe:4S]1+ state with ADP. C) The dithionite-reduced
[4Fe:4S]1+ state (nucleotide free). D) The TiIII-citrate-reduced [4Fe:4S]0
state (nucleotide free). Distinct hydrogen bonding patterns are
observed for the ADP-bound (A,B) and nucleotide free forms (C,D),
with little difference associated with the oxidation state changes from
2+ to 1+ in the presence of ADP (A,B), or from 1+ to 0 in the
nucleotide free form (C,D).
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genase proteins. These experiments provide the foundation to
pursue the crucial non-resting states with substrates, inter-
mediates and inhibitors.[34–37]
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